Top Medical Searches

Roche CEO says new drugs will offset biosimilar incursions

ZURICH (Reuters) – Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals’ copies through its new medicines, Chief Executive Severin Schwan said on Tuesday.

 Read more…

Be Sociable, Share!
March 13th, 2018 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us